Seeking Alpha

VSAR
  Versartis, Inc. - NASDAQ

8/31/2014, 4:26 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
VSAR vs. ETF Alternatives
Company Description
Versartis Inc is a development stage biopharmaceutical company developing therapeutic proteins for the treatment of metabolic diseases and endocrine disorders.
Sector: Healthcare
Industry: Drugs - Generic
Country: United States